ArticleFrontiers in neurology2020

Efficacy and Safety of Rituximab in Chinese Children With Refractory Anti-NMDAR Encephalitis.

Xiangjun Dou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.